Form 4: Bio-Key International Director Acquires Shares in Lieu of Board Fees

Robert J. Michel, a director at Bio-Key International, acquired 3,897 shares of common stock as payment for board meeting attendance fees.

Summary

• Robert J. Michel, a director of Bio-Key International, Inc., filed a Form 4 on May 12, 2025, reporting a change in beneficial ownership.
• On May 8, 2025, Michel acquired 3,897 shares of common stock.
• These shares were issued under the Issuer's 2023 Stock Incentive Plan as payment for board meeting attendance fees.
• Following the transaction, Michel directly owns 17,303 shares of Bio-Key International, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction of a director receiving stock compensation. It doesn't indicate any major positive or negative development for the company.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Industry Context

Directors receiving stock in lieu of cash compensation is a fairly common practice, especially for smaller companies, as it helps conserve cash and aligns the interests of the directors with those of the shareholders.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates

Keywords

Form 4, beneficial ownership, BIO-KEY INTERNATIONAL, BKYI, Robert J. Michel, director, stock incentive plan, board fees, common stock